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Gestational weight gain as a risk factor for hypertensive
disorders of pregnancy
Corrie Macdonald-Wallis, PhD; Kate Tilling, PhD; Abigail Fraser, PhD; Scott M. Nelson, PhD, MRCOG;
Debbie A. Lawlor, PhD, FFPH
OBJECTIVE: Pregnancy interventions to limit gestational weight gain women weighing 90 kg or less before pregnancy; OR, 1.24; 95% CI,
(GWG) have been proposed as a means of preventing hypertensive
disorders of pregnancy (HDP); however, it is currently unclear whether
GWG has a causal influence on the development of HDP. Thus, we
aimed to determine whether GWG in early pregnancy is a risk factor for
preeclampsia and gestational hypertension and whether GWG pre-
cedes the increases in blood pressure in normotensive women across
pregnancy.
STUDY DESIGN: We examined repeat antenatal clinic measurements
of weight and blood pressure (median of 12 and 14 per woman,
respectively) of 12,522 women in the Avon Longitudinal Study of
Parents and Children.
RESULTS: Greater prepregnancy weight was associated with an
increased risk of gestational hypertension and preeclampsia per 10 kg
of prepregnancy weight: odds ratio (OR), 1.80; 95% confidence interval
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See Journal Club, page 3911.03e1.49 and OR, 1.61; 95% CI, 1.18e2.19 for women weighing
more than 90 kg. Fully adjusted odds ratios for gestational hypertension
and preeclampsia per 200 g per week GWG up to 18 weeks were OR,
1.26; 95% CI, 1.16e1.38 and OR, 1.31; 95% CI, 1.07e1.62. In
normotensive women, GWG in early pregnancy was associated posi-
tively with blood pressure change in midpregnancy and negatively with
blood pressure change in late pregnancy. In all gestational periods,
GWG was positively associated with concurrent blood pressure change.
However, there was no evidence that blood pressure changes in any
period were associated with subsequent GWG.
CONCLUSION: These findings suggest that GWG in early pregnancymay
be a potential target for interventions aimed at reducing the risk of HDP.
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2013;209:327.e1-17.he hypertensive disorders of preg-T nancy (HDP), including gestational
hypertension and preeclampsia, remain a
leading cause of maternal and perinatal
mortality andmorbidityworldwide1-5 and
can affect up to 10% of pregnancies.6 Atpresent, effective treatments are limited,
and consequently, there is considerable
interest in their prevention. Prepregnancy
maternal adiposity is the strongest modi-
ﬁable risk factor for HDP7-10 and thus
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OCTOBER 2013 Amerihowever, it is increasingly recognized
that reducing overweight/obesity in all
women of reproductive age is extremely
difﬁcult. As a result there has been
increased interest in the extent to which
gestational weight gain (GWG) may in-
ﬂuence HDP and hence provide a po-
tential target for interventions aimed at
reducing its risk.11
Several studies have shown that
HDParemore likely to develop inwomen
who have greater GWG12-15; however,
most of these studies have important
methodological limitations.15 The pri-
mary concern is that previous studies
have related total GWG across pregnancy
to the risk of HDP. This is problematic
because women who develop HDP are
more likely to experience edema during
pregnancy than women who remain
normotensive,16 and this in turn may
result in greater GWG. Therefore, a pos-
itive association of total GWG with HDP
could represent increased edema in
womenwith HDP, causing greater weightcan Journal of Obstetrics& Gynecology 327.e1
Research Obstetrics www.AJOG.orggain, rather than greater GWG inﬂu-
encing increases in blood pressure.17
Furthermore, although a recent meta-
analysis of interventions designed to limit
GWGdid show a reduction inHDP,18 this
could be explained by the treatment of
gestational diabetes mellitus that oc-
curred in the 2 largest studies contrib-
uting to the metaanalysis.19,20
Therefore, clariﬁcation of whether
greater GWG precedes HDP and there-
fore could be a potential causal risk factor
is urgently needed. The primary aim of
this study was to examine whether GWG
up to 18 weeks’ gestation is associated
with the subsequent development of
HDP. GWG prior to 18 weeks’ gestation,
the time of the nadir in blood pressure,21
is unlikely to be affected by edema caused
by HDP because it occurs before blood
pressure begins to increase, and generally
clinical edema does not occur until the
second half of pregnancy.22
To further examine whether GWG
inﬂuences blood pressure in pregnancy,
we also investigated whether greater
GWG in different periods of pregnancy
precedes greater increases in blood pres-
sure. In this second analysis, we excluded
women with HDP to exclude the possi-
bility that the relationships are explained
by changes in weight caused by HDP.
MATERIALS AND METHODS
The Avon Longitudinal Study of Parents
and Children (ALSPAC) is a prospective
birth cohort study investigating the health
and development of children. The study
has been described in full elsewhere23 and
on the website (Available at: www.bris.ac.
uk/alspac. Accessed March 20, 2013).
Women with expected delivery dates be-
tween April 1, 1991, and Dec. 31, 1992,
who were living in a deﬁned area of Avon
during their pregnancy were eligible for
recruitment. Ethical approval was ob-
tained from the ALSPAC Law and Ethics
Committee and from theNational Health
Service local ethics committee.
A total of 14,541 women were
enrolled, 13,678 women had a singleton
live birth, and 13,461 of these had data
abstracted from obstetric records. We
excluded women who reported having
a previous diagnosis of hypertension
outside pregnancy (n ¼ 445), leaving327.e2 American Journal of Obstetrics& Gynecol13,016 women of whom 12,522 had at
least 1 measurement of blood pressure
and weight during pregnancy.
Antenatal blood pressure and weight
measurements
All weight and blood pressure measure-
ments (median [interquartile range] per
woman: 12 [10e14] and 14 [11e16],
respectively) taken routinely as part of
antenatal care by midwives or obstetri-
cians were abstracted from obstetric re-
cords by 6 trained research midwives.
There was no between-midwife varia-
tion in the mean values of the data
abstracted, and error rates were consis-
tently less than 1% in repeated data entry
checks.
Gestational age at delivery was calcu-
lated as the difference between the de-
livery date and the mother’s reported last
menstrual period date or updated if ul-
trasound information was available,
which led to a reassessment of gestation.
At the time of recruitment, ﬁrst-trimester
ultrasound gestational age dating was not
routine clinical practice, and the infor-
mation abstracted from clinical records
did not indicate which few women had
their gestational age adjusted.
HDP was deﬁned according to
International Society for the Study of
Hypertension in Pregnancy criteria
of systolic blood pressure (SBP) of
140 mm Hg or greater or diastolic blood
pressure (DBP) of 90 mmHg or greater,
measured on 2 occasions after 20 weeks’
gestation for gestational hypertension
and the same criteria in conjunction
with proteinuria of at least 1þ on
dipstick testing for preeclampsia.24
Prepregnancy weight was obtained
from the predicted weight at 0 weeks’
gestation from multilevel models based
on the antenatal weight measurements
(see the following text). This correlated
highly with self-reported prepregnancy
weight from a questionnaire adminis-
tered during pregnancy (r ¼ 0.94). Ab-
solute weight gain was calculated by
subtracting the predicted weight at 8
weeks (because there were few measure-
ments prior to this time) from the pre-
dictedweight at 40 weeks’ gestation, using
a multilevel model for weight change
across pregnancy including women withogy OCTOBER 2013term pregnancies (see the following text)
and was then categorized according
to Institute of Medicine (IOM) recom-
mendations (Appendix; Supplementary
Table 1).17 Consistent results to those
presented here for associations of IOM
categories with HDP were found if self-
reported prepregnancy weight and the
last antenatal weight measurement (in
which this was after 37 weeks) were used
to deﬁne absolute weight gain.
Maternal characteristics
Maternal age at delivery and offspring
sex were abstracted from obstetric re-
cords. Maternal height, parity, highest
educational qualiﬁcation, and smoking
status were obtained from question-
naires administered during early preg-
nancy. Prepregnancy body mass index
(BMI) was calculated as predicted
prepregnancy weight (kilograms)/self-
reported height (meters) squared and
classiﬁed according to the World Health
Organization categories (Supplementary
Table 1). Smoking status was classed as
never for women who did not smoke
immediately prior to or during preg-
nancy, before pregnancy/ﬁrst trimester
for women who smoked only immedi-
ately prior to pregnancy or in the ﬁrst
3 months of gestation, or throughout for
women who continued to smoke after
the ﬁrst trimester.
Statistical analysis
IOM categories of GWG and risk of
HDP
For women with complete data on IOM
categories of GWG and covariates (n ¼
9596), we used a multinomial regression
model to assess the risk of develop-
ing gestational hypertension and pre-
eclampsia (with normotensive women as
the comparison group) by the IOM
category of GWG, adjusting for pre-
pregnancy BMI, maternal age, parity,
smoking, education, and sex of offspring.
Early pregnancy GWG and risk of HDP
Using all weight measurements up to
18 weeks’ gestation for women with at
least 1 weight measurement prior to
this time (n ¼ 11,760), we developed
a multilevel model for the change in
weight with gestational age, using a
TABLE 1
Characteristics of the cohort and subsamples by HDP
Maternal
characteristic
Full dataset (total n[ 12,522) mean (SD) or %
Complete data for GWG at £18 weeks and HDP analysis
(n[ 9536), mean (SD) or %
Complete data for
GWG and BP
change analysis
(n[ 7975) mean
(SD) or %
Normotensive
(n[ 10,346)
Gestational
hypertension
(n[ 1892)
Preeclampsia
(n[ 284)
Normotensive
(n[ 7869)
Gestational
hypertension
(n[ 1466)
Preeclampsia
(n[ 201)
Normotensive
(n[ 7975)
Height, cm (n ¼ 9085) (n ¼ 1674) (n ¼ 243)
163.81 (6.66) 164.70 (6.95) 162.97 (6.69) 163.88 (6.61) 164.71 (6.96) 162.99 (6.71) 163.94 (6.59)
Age, y (n ¼ 10,346) (n ¼ 1892) (n ¼ 284)
15-19 5.08 3.96 8.10 3.24 2.52 3.48 3.60
20-24 19.04 21.93 26.41 16.02 19.37 28.36 16.20
25-29 38.49 39.11 34.86 39.69 40.72 35.32 39.44
30-34 27.94 24.68 17.96 30.73 27.08 20.40 30.39
35 9.44 10.31 12.68 10.32 10.30 12.44 10.37
Parity (n ¼ 9610) (n ¼ 1758) (n ¼ 255)
Nulliparous 42.58 57.05 70.98 42.66 57.71 71.64 42.39
Multiparous 57.42 42.95 29.02 57.34 42.29 28.36 57.61
Smoking in
pregnancy
(n ¼ 9713) (n ¼ 1771) (n ¼ 256)
Never 65.42 69.85 74.22 68.31 72.24 75.12 68.13
Before pregnancy/first
trimester
13.60 14.85 16.41 12.99 14.05 17.91 13.25
Throughout 20.98 15.30 9.38 18.71 13.71 6.97 18.62
Highest
qualification
(n ¼ 9253) (n ¼ 1707) (n ¼ 242)
CSE/vocational 30.41 29.23 28.10 28.20 27.49 27.36 28.30
O level 33.99 36.44 36.78 34.63 37.18 36.82 34.51
A level 22.72 21.32 23.55 23.79 22.17 24.38 23.59
Degree 12.88 13.01 11.57 13.38 13.17 11.44 13.61
Macdonald-Wallis. Weight gain and blood pressure in pregnancy. Am J Obstet Gynecol 2013. (continued)
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327.e4 American Journal of Obstetrics& Gynecology OCTOBER 2013linear slope. The model had 2 levels:
measurement occasion (occasion level)
within woman (individual level); and 2
individual-level random effects repre-
senting weight at 0 weeks (the intercept;
referred to as prepregnancy weight) and
average GWG per week up to 18 weeks.
The individual-level random effects
were then used as exposure variables in
multinomial logistic regression models.
The outcome variable had 3 categories:
normotensive (comparison group), ges-
tational hypertension, and preeclampsia.
We adjusted for maternal height, age,
parity, smoking, education, and offspring
sex, and to examine the exposure of
GWG up to 18 weeks, we additionally
adjusted for prepregnancy weight. We
tested for nonlinearity in these associa-
tions using fractional polynomials, and
any nonlinear relationships were ap-
proximated using linear splines. We also
tested for an interaction between pre-
pregnancy BMI category and GWG up
to 18 weeks.
GWG and changes in blood pressure in
normotensive women
Wehave previously ﬁttedmultilevel linear
spline models for changes in SBP, DBP,21
and weight25 with gestational age sepa-
rately. We combined these models to
develop 2 bivariatemultilevel linear spline
models,26 the ﬁrst including changes in
SBP and weight in parallel and the second
including changes in DBP and weight in
parallel (Supplementary material).
This analysis was restricted to nor-
motensive women who had a term
pregnancy (37 weeks) (n¼ 9855). The
model with SBP and weight as outcomes
had 5 random-effect parameters for SBP:
SBP at 8 weeks (baseline) and rate of
SBP change at 8-18 weeks (early preg-
nancy), 18-29 weeks (midpregnancy),
29-36 weeks (late pregnancy), and
36 weeks onward (very late pregnancy)
and 4 random-effect parameters for
weight: weight at 0 weeks (prepregnancy
weight) and rate of GWG at 0-18 weeks
(early pregnancy), 18-29 weeks (mid-
pregnancy), and 29 weeks onward (late
pregnancy). The model with DBP and
weight as outcomes had the equivalent
random-effects parameters for DBP as
for SBP and the same weight parameters.
www.AJOG.org Obstetrics Research(Estimates of these parameters are shown
in Supplementary Table 2.)
In the second stage, we used the
bivariate multilevel models to derive
associations of prepregnancy weight and
GWG (exposures) with blood pressure
change (outcome),26 adjusting for ma-
ternal height, age, parity, smoking, edu-
cation, and offspring sex in model 1. In
model 2 we additionally adjusted for
baseline weight and SBP/DBP and GWG
and SBP/DBP changes in periods of
pregnancy prior to the exposure period.
We then conceptualized GWG as the
outcome with changes in blood pressure
as a potential risk factor. We therefore
derived associations of GWG in each
period of gestation (outcome) with SBP/
DBP at 8 weeks and SBP/DBP change in
previous periods of gestation (exposure).
We adjusted for maternal character-
istics in model 1. In model 2 we addi-
tionally adjusted for baseline weight and
SBP/DBP, GWG, and the SBP/DBP
change in all periods prior to the expo-
sure period and GWG in the exposure
period.
We completed sensitivity analyses,
restricting to women who contributed at
least 8 measurements of blood pressure
and weight to the bivariate models (n ¼
6666), and second, restricting to women
who contributed no more than 11 mea-
surements (n¼ 6135). The ﬁndings were
not meaningfully changed from those in
the main analyses. We also performed a
sensitivity analysis using an 8 week
baseline for weight.
Statistical analyses were carried out
usingMLwiNversion 2.25, STATAversion
12.1 and runmlwin27 and reffadjust28
Stata commands (StataCorp, College
Station, TX).
RESULTS
The characteristics of women in the full
dataset, and subsets with complete data
for each analysis, by categories of HDP
are shown in Table 1, and distributions of
prepregnancy BMI and early-pregnancy
GWG are shown in Supplementary
Figures 1 and 2, respectively. Each sub-
set had similar characteristics to the full
dataset.
Nulliparous women, nonsmokers, and
women aged over 35 years were morelikely to develop HDP (Supplementary
Table 3). Gaining more than the IOM
recommended weight was associated
with an increased risk of gestational hy-
pertension and preeclampsia compared
with gaining within the recommended
range (Figure; odds ratio [OR], 1.51;
95% conﬁdence interval [CI], 1.32e1.73
and OR, 2.14; 95% CI, 1.46e3.12,
respectively). Also, lower than IOM-
recommended GWG was associated
with a reduced risk of gestational hyper-
tension (OR, 0.75; 95% CI, 0.62e0.91)
and preeclampsia (OR, 0.70; 95% CI,
0.38e1.27) compared with GWG within
the recommended range (although the
conﬁdence interval was wide for pre-
eclampsia and included the null).
Early-pregnancy GWG and risk of HDP
A higher prepregnancy weight was
associated with an increased risk of
developing gestational hypertension and
preeclampsia (Table 2). This association
was nonlinear, with evidence of a
stronger association between prepreg-
nancy weight and gestational hyperten-
sion for women who weighed 90 kg or
less than for those who weighed more
than 90 kg before pregnancy, although
associations with preeclampsia were
similar in each group.
After adjustment for prepregnancy
weight, greater early-pregnancy GWG
was independently associated with an
increased risk of developing gestational
hypertension and preeclampsia (per
200 g/wk increase in GWG up to
18 weeks: OR, 1.26; 95% CI, 1.16e1.38
and OR, 1.31; 95% CI, 1.07e1.62,
respectively).
These ﬁndings are further illustrated
by Table 3, which shows the predicted
probabilities of developing gestational
hypertension or preeclampsia for dif-
ferent prepregnancy weights and rates
of early-pregnancy GWG. This shows
clearly that, even among women with
healthy prepregnancy weights (eg, 50 or
60 kg), those who gain more weight
have important increases in the risk
of gestational hypertension and pre-
eclampsia. We found no evidence that
associations of GWG up to 18 weeks
with the risk of gestational hyperten-
sion and preeclampsia differed byOCTOBER 2013 Ameriprepregnancy BMI category (P value for
interaction ¼ .18).
Associations of prepregnancy weight
and GWG with subsequent blood
pressure change in normotensive
women
Analysis of the mean differences in SBP
and DBP change for a 200 g/wk increase
in GWG in the same and preceding
period of gestation are shown in Table 4.
For completeness, associations of all
possible combinations of prepregnancy
weight and GWG in each gestational
period with later SBP and DBP changes
are also shown in Supplementary
Tables 4 and 5, respectively.
In each period of pregnancy,GWGwas
positively associated with the changes
in SBP and DBP that occurred during
the same gestational period (Table 4).
In addition, an increase in GWG in early
pregnancy (up to 18 weeks) was associ-
ated with a greater increase in SBP
and DBP in the subsequent period of
gestation (midpregnancy: 18-29 weeks)
(Table 4). However, greater GWG in
early pregnancy was also associated
with a smaller increase in SBP and
DBP in late pregnancy (Supplementary
Tables 4 and 5). GWG in midpregnancy
(18-29 weeks) was not associated with
SBP or DBP change in late pregnancy
(29-36 weeks) (Table 4).
Associations of blood pressure
changes with subsequent GWG
To assess whether rises in blood pressure
may precede increases in edema and thus
weight gain, even in these normotensive
women, we also examined associations of
changes in SBPandDBPwith subsequent
GWG (Table 5). All possible associations
of baseline SBP and DBP and changes in
SBP and DBP with GWG in later periods
of gestation are shown in Supplementary
Table 6. In fully-adjusted models, there
were no associations between SBP or
DBP change and GWG in subsequent
periods of pregnancy. There was evidence
of positive associations between SBP
and DBP at baseline and GWG in early
pregnancy (Supplementary Table 6).
However, when we repeated the bivariate
analyses with the baseline set at 8 weeks
for weight, neither SBP nor DBP atcan Journal of Obstetrics& Gynecology 327.e5
FIGURE
ORs (95% CI) for gestational hypertension and preeclampsia associated
with IOM categories of total weight gain (n[ 9596)a
CI, confidence interval; IOM, Institute of Medicine; OR, odds ratio.
a Adjusted value for maternal prepregnancy body mass index, age, parity, smoking, education, and offspring sex.
Macdonald-Wallis. Weight gain and blood pressure in pregnancy. Am J Obstet Gynecol 2013.
Research Obstetrics www.AJOG.orgbaseline was associated with GWG in
early pregnancy after adjustment for
baseline weight (no other ﬁndings were
changed in this sensitivity analysis).
COMMENT
In this large cohort, greater prepregnancy
weight and GWG in early pregnancy
were both independently associated with
an increased risk of gestational hyper-
tension and preeclampsia. We also found
that, in normotensive women, gainingTABLE 2
Associations of prepregnancy weigh
Exposure variablesb Subgro
Prepregnancy weight (10 kg) 90 kg
>90 kg
GWG up to 18 weeks (200 g/wk) All wom
CI, confidence interval; GWG, gestational weight gain; HDP, hyp
a Both models are adjusted for maternal height (continuous; c
smoked); education (reference, O level); and offspring sex (re
splines: 90 kg and >90 kg); b Prepregnancy weight and GW
Because of strong evidence for nonlinear associations betwee
differ.
Macdonald-Wallis. Weight gain and blood pressure in pregn
327.e6 American Journal of Obstetrics& Gynecolmore weight in early pregnancy was
associated with a greater increase in
blood pressure in the subsequent pe-
riod of gestation. In addition, in each
period of gestation, GWG was posi-
tively associated with the change in
blood pressure during the same gesta-
tional period. These associations are
unlikely to be explained by blood
pressure increases leading to increased
edema because we found little evi-
dence that blood pressure changest and early-pregnancy GWG with HDP (n
up
Gestational hyperte
OR 95%
prepregnancy weight 1.80 1.7
prepregnancy weight 1.24 1.0
en 1.27 1.1
ertensive disorders of pregnancy; OR, odds ratio.
entered around the mean of 164 cm); age (reference, 25-29 years
ference, male). The model with GWG up to 18 weeks as the exposur
G up to 18 weeks were obtained using the residuals from a linear mu
n prepregnancy weight and these outcomes, results are presented fo
ancy. Am J Obstet Gynecol 2013.
ogy OCTOBER 2013were associated with subsequent GWG
in any period of pregnancy in these
women.
The review of outcomes associated
withGWGbyViswanathan et al15 did not
ﬁnd any strong evidence of an association
of GWG with risk of HDP. Although the
majority of studies reviewed reported a
positive association, the review authors
noted that the number of studies was
limited and most were assessed to be of
weak design.15 Since the review, 2 studies
have reported a positive relationship of
excess GWG according to 1990 IOM
recommendations with a risk of HDP
in 5377 Canadian29 and 1043 Latina
women,30 respectively, and others have
reported positive associations between
net GWG and HDP risk.12,13 However,
because IOM criteria combine prepreg-
nancy BMI and GWG over the whole of
pregnancy, it is not possible using these
criteria to distinguish the impact of pre-
pregnancy BMI from GWG, and none
of the studies have addressed whether it
is edema associated with HDP that is
driving the association.
Our study was limited by the use of
routinely collected clinic blood pressure
and weight measurements, which is
likely to produce random measurement
error but unlikely to introduce bias. It
also has the advantage that our results
could be translated into clinical practice
if they are replicated because the mea-
sures represent those obtained in clinical
practice. Women who develop pre-
eclampsia have reduced plasma volume[ 9536)a
nsion Preeclampsia
CI OR 95% CI
0e1.91 1.71 1.49e1.95
3e1.49 1.61 1.18e2.19
6e1.38 1.31 1.07e1.61
); parity (reference, nulliparous); smoking (reference, never
e is additionally adjusted for prepregnancy weight (2 linear
ltilevel model for weight change up to 18 weeks’ gestation.
r subgroups of women in whom magnitudes of associations
TABLE 3
Predicted probabilities of HDP by prepregnancy weight and
early-pregnancy GWG (n[ 9536)a
Prepregnancy
weight, kg
GWG up to
18 wks, g/wk
Probability of gestational
hypertension, % (SE)
Probability of
Preeclampsia, % (SE)
50 200 11.5 (0.9) 1.8 (0.4)
400 14.1 (1.0) 2.3 (0.5)
600 17.0 (1.4) 2.9 (0.7)
60 200 19.4 (1.2) 2.9 (0.5)
400 23.2 (1.4) 3.6 (0.6)
600 27.3 (2.0) 4.4 (1.0)
70 200 30.7 (1.7) 4.4 (0.8)
400 35.4 (1.9) 5.3 (1.0)
600 40.4 (2.6) 6.2 (1.5)
80 200 44.2 (2.3) 6.0 (1.2)
400 49.3 (2.5) 7.0 (1.5)
600 54.1 (3.2) 7.9 (2.1)
90 200 57.9 (2.8) 7.5 (1.8)
400 62.3 (3.0) 8.4 (2.1)
600 66.1 (3.6) 9.2 (2.8)
GWG, gestational weight gain; HDP, hypertensive disorders of pregnancy; SE, standard error.
a Predicted probabilities are for a woman of average height (164 cm), age (25-29 years), nulliparous, having never smoked
during pregnancy, O level educational qualification, and having a male offspring.
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www.AJOG.org Obstetrics Researchexpansion in early pregnancy compared
with women who remain normoten-
sive.17,31,32 However, studies have sug-
gested that this is due to increased
capillary permeability and a redistribu-
tion of plasma to interstitial ﬂuid.32,33TABLE 4
Associations of GWG with subsequen
Exposure
Average weight
change (200 g/wk)
Outcome
Average SBP/DBP chan
same and subsequent
Early pregnancy
(0-18 wks)
Same period
Subsequent period
Midpregnancy
(18-29 wks)
Same period
Subsequent period
Late pregnancy
(29 wks)
Same period (2 parts)
CI, confidence interval; DBP, diastolic blood pressure; GWG, ge
a Adjusted for maternal height, age, parity, smoking, education
(equivalent to model 2 in Supplementary Tables 4 and 5); b Es
across pregnancy and the other including all of the women’s
Macdonald-Wallis. Weight gain and blood pressure in pregnWe were unable to account for plasma
volume expansion in our analyses, but
any bias in our ﬁndings resulting from
the reduction in plasma volume would
be expected to attenuate associations
toward the null.t blood pressure change (n[ 7975)a,b
ge (mm Hg/wk) in the
periods of gestation
SBP change
Mean
difference 95%
Early pregnancy (8-18 wks) 0.06 (0.0
Midpregnancy (18-29 wks) 0.04 (0.0
Midpregnancy (18-29 wks) 0.09 (0.0
Late pregnancy (29-36 wks) 0.00 (e0
Late pregnancy (29-36 wks) 0.11 (0.0
Very late pregnancy (36 wks) 0.14 (0.0
stational weight gain; SBP, systolic blood pressure.
, and offspring sex; prepregnancy weight; SBP/DBP at baseline; and
timates were obtained from 2 bivariate multilevel spline models: one
weight and DBP measurements across pregnancy, restricting to wom
ancy. Am J Obstet Gynecol 2013.
OCTOBER 2013 AmeriThe study’s strengths are its large size,
inclusion of women with a range of
BMIs, the high number of repeated
weight and blood pressure measure-
ments, and longitudinal modeling of
GWG and blood pressure changes in
different periods of pregnancy. Because
of the repeat measurements of blood
pressure and proteinuria, we were able to
apply a standard international deﬁnition
of HDP to all women and not rely on
clinical diagnoses.
Outside pregnancy, greater body mass
is an established risk factor for high blood
pressure,34,35 and therefore, the associa-
tion of greater GWG in early pregnancy
with HDP and of GWG throughout
pregnancy with blood pressure increases
in women without HDP may reﬂect the
effect of greater maternal pregnancy
adiposity acquisition on blood pressure.36
Also, markers of inﬂammation,
interleukin-6 and C-reactive protein, are
increased in obese pregnant women, and
this inﬂammation may contribute to
endothelial dysfunction.37 Inﬂamma-
tion, measured by C-reactive protein
concentrations, has been found in 1
study tomediate the association between
prepregnancy BMI and preeclampsia
risk.38 In our study, we were unable to
examine this mechanism. Alternatively,
these associations may be partly ex-
plained by biological changes related to
pregnancy inﬂuencing both GWG and
blood pressure change or from anDBP change
CI
Mean
Difference 95% CI
2e0.10) 0.03 (0.00e0.05)
0e0.07) 0.03 (0.00e0.05)
6e0.12) 0.04 (0.01e0.06)
.06 to 0.06) 0.01 (e0.03 to 0.06)
6e0.16) 0.08 (0.04e0.12)
3e0.25) 0.10 (0.01e0.18)
weight and SBP/DBP change prior to the exposure period
including all of the women’s weight and SBP measurements
en who had normotensive pregnancies.
can Journal of Obstetrics& Gynecology 327.e7
TABLE 5
Associations of blood pressure changes with subsequent GWG (n[ 7975)a,b
Exposure
Average SBP/DBP
change (mm Hg/wk)
Outcome
Average weight change (200 g/wk) in
the subsequent period of gestation
Mean
difference 95% CI
SBP change
Early pregnancy (8-18 wks) Subsequent period Midpregnancy (18-29 wks) 0.06 (e0.06 to 0.18)
Midpregnancy (18-29 wks) Subsequent period Late pregnancy (29 wks) e0.01 (e0.17 to 0.15)
DBP change
Early pregnancy (8-18 wks) Subsequent period Midpregnancy (18-29 wks) 0.02 (e0.18 to 0.24)
Midpregnancy (18-29 wks) Subsequent period Late pregnancy (29 wks) 0.14 (e0.07 to 0.36)
CI, confidence interval; DBP, diastolic blood pressure; SBP, systolic blood pressure.
a Adjusted for maternal height, age, parity, smoking, education, and offspring sex; prepregnancy weight; SBP/DBP at baseline; weight; and SBP/DBP change in all periods of pregnancy prior to the
exposure period and weight change in the exposure period (equivalent to model 2 in Supplementary Table 6); b Estimates were obtained from 2 bivariate multilevel spline models: one including all
of the women’s weight and SBP measurements across pregnancy and the other including all of the women’s weight and DBP measurements across pregnancy, restricting to women who had
normotensive pregnancies.
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Research Obstetrics www.AJOG.orgunderlying predisposition to obesity and
cardiovascular risk.39
Although our observational data are
not able to prove causality, they are a step
change from the previous publications
and demonstrate temporality by showing
that GWG precedes the development of
HDP and also a greater increase in blood
pressure.
We have also adjusted for a wide range
of potential confounders in our analyses.
If GWG does have a causal inﬂuence on
blood pressure change, the potential im-
plications are that limiting GWG in
pregnancy may be able to both reduce the
incidence ofHDPand the severity in those
who develop HDP. A recent systematic
review and metaanalysis of pregnancy
interventions aimed at managing weight
gain estimated a 33% reduction in the risk
of preeclampsia and a 70% reduction in
the risk of gestational hypertension had
been achieved through interventions that
limited GWG.18 However, the 2 largest
included studies, which drove the associ-
ations, included only women at high
risk for gestational diabetes and an inter-
vention aimed at preventing its develop-
ment. Hence, it is unclear whether the
decreased risk of HDP was achieved
through themonitoring andmanagement
of gestational diabetes because the con-
ditions are strongly linked.11
The clinical signiﬁcance of our ﬁndings
is indicated by the potential risk reduc-
tion for preeclampsia that could be327.e8 American Journal of Obstetrics& Gynecolachieved by optimizingGWG.Our results
show that the risk of gestational hyper-
tension and preeclampsia is markedly
lower in women with lower GWG in all
strata of prepregnancy weight (Table 3).
These results combined with evidence
from recent trials showing that lifestyle
interventions can effectively limit GWG,
show the potential to prevent HDP by
targeting GWG. Furthermore, the risk
reduction that might be achieved by
targeting GWG compares favorably with
the relative risk reduction of 0.75 (95%
CI, 0.66e0.85) observed with antiplate-
let agents for the risk of preeclampsia
and may be independent of this.6 How-
ever, any beneﬁts of limiting GWG
in terms of reducing HDP risk should
be balanced with the potential adverse
effects because there is evidence of an
increased risk of preterm birth and
small-for-gestational-age offspring at the
lower end of the GWG distribution.15
We were unable to assess the optimum
levels of GWG required to achieve this
balance in this study.
In summary, we found that greater
GWG up to 18 weeks, independently of
prepregnancyweight, was associatedwith
a greater risk of developing HDP and
in normal pregnancy was associated with
a greater midpregnancy rise in blood
pressure. GWG in all periods of gestation
were positively associated with concur-
rent rises in blood pressure. This suggests
that interventions aimed at limitingogy OCTOBER 2013GWG from early pregnancy onward may
have the potential to reduce the incidence
of gestational hypertension and pre-
eclampsia. Our results support estab-
lishing randomized trials in nonspeciﬁc
populations to assess the effectiveness of
such interventions in the prevention of
these disorders. -ACKNOWLEDGMENTS
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APPENDIX
Supplemental Methods
Development of the bivariate linear
spline random-effects models
The data were divided into 2 week in-
tervals by gestational age, starting from
4 weeks’ gestation, and in cases in which
an individual had multiple weight or
blood pressure measurements within
any 2 week interval, 1 weight and 1 blood
pressure measurement was chosen at
random from this interval for inclusion
in the sample for analysis. This was to
prevent individuals with a high number
of antenatal visits from having too great
an inﬂuence on the models. After this
process, there remained a median of
10 weight measurements per woman,
with a range of 1e17, and a median of
10 blood pressure measurements per
woman, with a range of 1e17.can Journal of Obstetrics& Gynecology 327.e9
Research Obstetrics www.AJOG.orgUnivariate linear spline models have
previously been ﬁtted to systolic blood
pressure (SBP), diastolic blood pressure
(DBP)1 and weight.2 Separate models
were ﬁtted with SBP, DBP, and weight
as the outcome variables (Y), and for
each model, gestational age in weeks
was used as the exposure variable (X).
The models had 2 levels: antenatal visit
and individual because there were
multiple antenatal visits per woman.
The knot points (indicating changes
in slope) for these models were deter-
mined by initially ﬁtting fractional
polynomial curves3 to each of SBP,
DBP, and weight to describe the shape
of the average patterns of change with
gestational age. Models with 2 or 3
knots were considered and the ﬁnal
positioning and number of knots was
selected as that which optimally ful-
ﬁlled the criteria of a high model log
likelihood, a close ﬁt to the fractional
polynomial curve, and good ﬁt of the
model predicted values to observed
values over the whole course of preg-
nancy. The best-ﬁtting models for both
SBP and DBP had 3 knots at 18, 30, and
36 weeks’ gestation, and the model for
weight had 2 knots at 18 and 28 weeks’
gestation. Each contained individual-
level random effects for the intercept
and each of the splines.
Because the second knot point for SBP
and DBP (at 30 weeks) was in a similar327.e10 American Journal of Obstetrics& Gyneclocation to the second knot for weight
(28 weeks), for the bivariate spline
models, we shifted this knot point 1 week
earlier for SBP and DBP and 1 week later
for weight and used knots at 18, 29, and
36 weeks for SBP and DBP and knots
at 18 and 29 weeks for weight. This
was for simplicity and interpretability
so that the ﬁrst 2 periods of blood pres-
sure change and gestational weight gain
(GWG) had the same endpoints and
did not substantially alter the ﬁt of the
models.
Few measurements were available
prior to 8 weeks so the baseline was set
at 8 weeks’ gestation for SBP and DBP
because blood pressure begins to
decrease early in pregnancy but was set at
0 weeks for weight because weight
changes little in very early pregnancy.
The coefﬁcients from these unadjusted
bivariate models model are shown in
Supplementary Table 2.
We then added the maternal charac-
teristics of height (continuous), age (<20,
20-24, 25-29, 30-34, 35 years), parity
(nulliparous, multiparous), smoking
(never, before pregnancy/ﬁrst trimester/
throughout pregnancy), education (cer-
tiﬁcate of secondary education [CSE]/
vocational, O level, A level, degree), and
offspring sex (male/female) into each of
these models as main effects and in-
teractions with each of the splines, with
separate effects for SBP/DBP and weight.ology OCTOBER 2013Derivation of associations of
changes in weight with changes in
blood pressure from the bivariate
multilevel spline models
We derived associations of the weight
and GWG parameters with baseline SBP/
DBP and SBP/DBP change parameters
using the variance-covariance matrix
of random effects from each of the
models using formulae described by
Macdonald-Wallis et al4 implemented
using the REFFADJUST package in
STATA (StataCorp, College Station, TX).5
Adjustment for previous GWG and
SBP/DBP changes was also made
using the variance-covariance matrix of
random effects. Because the variances
and covariances of the random effects
were estimated with uncertainty in the
bivariate models, for both of the models,
we generated 10,000 realizations of
each of the variances and covariances of
the random effects from a multivariate
normal distribution using the means,
variances, and covariances of these
estimates calculated by the bivariate
random-effects models. We then aver-
aged regression coefﬁcients over the
10,000 realizations and formed 95%
conﬁdence intervals for the regression
coefﬁcients using the 2.5th and 97.5th
percentiles of the distributions of these
regression coefﬁcients over the 10,000
realizations to fully incorporate the un-
certainty in the estimation procedure.4
SUPPLEMENTARY TABLE 1
IOM-recommended total GWG by prepregnancy BMI category
Prepregnancy BMI category Recommended absolute weight gain, kg
Underweight (<18.5 kg/m2) 12.5-18
Normal weight (18.5-24.9 kg/m2) 11.5-16
Overweight (25.0-29.9 kg/m2) 7-11.5
Obese (30.0 kg/m2) 5-9
BMI, body mass index; GWG, gestational weight gain; IOM, Institute of Medicine.
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Blood pressure and weight parameters from unadjusted bivariate models (n[ 9855)
Blood pressure/weight variable Mean Between-individual SD 95% CI reference range
SBP and weight model
SBP at 8 wks, mm Hg 111.00 7.75 (95.82e126.18)
SBP change, mm Hg/wk
8-18 wks e0.177 0.601 (e1.356 to 1.001)
18-29 wks 0.133 0.449 (e0.747 to 1.014)
29-36 wks 0.177 0.625 (e1.048 to 1.401)
36 wks 0.967 1.119 (e1.227 to 3.161)
Prepregnancy weight, kg 59.11 11.33 (36.90e81.32)
Weight change, kg/wk
0-18 wks 0.317 0.228 (e0.129 to 0.763)
18-29 wks 0.525 0.190 (0.154e0.897)
29 wks 0.448 0.213 (0.030e0.865)
DBP and weight model
DBP at 8 wks, mm Hg 65.39 5.48 (54.65e76.13)
DBP change, mm Hg/wk
8-18 wks e0.204 0.410 (e1.008 to 0.599)
18-29 wks 0.078 0.326 (e0.560 to 0.717)
29-36 wks 0.313 0.516 (e0.698 to 1.324)
36 wks 1.082 1.008 (e0.893 to 3.058)
Prepregnancy weight, kg 59.11 11.33 (36.90e81.32)
Weight change, kg/wk
0-18 wks 0.317 0.228 (e0.129 to 0.763)
18-29 wks 0.525 0.190 (0.154e0.897)
29 wks 0.448 0.213 (0.030e0.865)
CI, confidence interval; DBP, diastolic blood pressure; SBP, systolic blood pressure; SD, standard deviation.
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SUPPLEMENTARY TABLE 3
Associations of maternal characteristics with HDP
Maternal characteristic
Gestational hypertension Preeclampsia
Unadjusted Mutually adjusted Unadjusted Mutually adjusted
Height (per cm) (n ¼ 11002) 1.02 (1.01e1.03) 1.02 (1.01e1.03) 0.98 (0.96e1.00) 0.98 (0.96e1.00)
Age (n ¼ 12,522), y
<20 0.77 (0.59e0.99) 0.58 (0.40e0.82) 1.76 (1.11e2.79) 1.09 (0.54e2.20)
20-24 1.13 (0.99e1.29) 1.13 (0.96e1.32) 1.53 (1.13e2.08) 1.86 (1.30e2.66)
25-29 1 1 1 1
30-34 0.87 (0.77e0.99) 0.97 (0.84e1.11) 0.71 (0.50e1.00) 0.86 (0.58e1.27)
35 1.07 (0.90e1.28) 1.20 (0.98e1.46) 1.48 (1.01e2.18) 1.90 (1.20e3.02)
Parity (n ¼ 11,623)
Nulliparous 1 1 1 1
Multiparous 0.56 (0.50e0.62) 0.53 (0.48e0.60) 0.30 (0.23e0.40) 0.28 (0.20e0.38)
Smoking in pregnancy (n ¼ 11,740)
Never 1 1 1 1
Before pregnancy/first trimester 1.02 (0.88e1.18) 0.91 (0.78e1.08) 1.06 (0.76e1.49) 0.94 (0.65e1.36)
Throughout 0.68 (0.59e0.79) 0.67 (0.57e0.79) 0.39 (0.26e0.60) 0.31 (0.18e0.53)
Highest qualification (n ¼ 11,202)
CSE/vocational 0.90 (0.79e1.02) 1.01 (0.88e1.16) 0.85 (0.62e1.18) 0.98 (0.69e1.39)
O Level 1 1 1 1
A Level 0.88 (0.76e1.01) 0.82 (0.70e0.95) 0.96 (0.68e1.34) 0.90 (0.63e1.30)
Degree 0.94 (0.80e1.11) 0.81 (0.67e0.97) 0.83 (0.54e1.28) 0.82 (0.51e1.32)
Offspring sex (n ¼ 12,522)
Male 1 1 1 1
Female 0.93 (0.84e1.02) 0.92 (0.82e1.03) 0.98 (0.77e1.24) 0.94 (0.71e1.23)
CI, confidence interval; CSE, Certificate of Secondary Education; HDP, hypertensive disorders of pregnancy; OR, odds ratio.
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SUPPLEMENTARY TABLE 4
Associations of prepregnancy weight and GWG with subsequent SBP chan a
Weight variable
SBP at
8 wks, mm Hg
Average SBP change, mm
Early pregnancy
(8-18 wks)
Mean
difference 95% CI
Mean
difference 95% CI
Prepregnancy weight (10 kg)
Model 1 2.01 (1.70e2.33) 0.04 (0.00e0.08)
Average weight change
(200 g/wk)
Early pregnancy (0-18 wks) Model 1 0.02 (e0.02 to 0.07
Model 2 0.06 (0.02e0.10)
Midpregnancy (18-29 wks) Model 1
Model 2
Late pregnancy (29 wks) Model 1
Model 2
CI, confidence interval; GWG, gestational weight gain; SBP, systolic blood pressure.
a Model 1 was adjusted for maternal height, age, parity, smoking, education, and offspring sex. Model 2 was adjusted also for prepre
the exposure period.
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Hg/wkMid-pregnancy
(18-29 wks)
Late pregnancy
(29-36 wks)
Very late pregnancy
(‡36 wks)
Mean
difference 95% CI
Mean
difference 95% CI
Mean
difference 95% CI
e0.07 (e0.09 to e0.04) 0.02 (e0.02 to 0.06) e0.05 (e0.12 to 0.02)
) 0.05 (0.02e0.08) e0.09 (e0.14 to e0.04) 0.07 (e0.02 to 0.16)
0.04 (0.00e0.07) e0.10 (e0.15 to e0.05) 0.07 (e0.02 to 0.16)
0.10 (0.07e0.14) e0.03 (e0.08 to 0.02) 0.07 (e0.02 to 0.16)
0.09 (0.06e0.12) 0.00 (e0.06 to 0.06) 0.04 (e0.06 to 0.14)
0.08 (0.03e0.12) 0.13 (0.05e0.21)
0.11 (0.06e0.16) 0.14 (0.03e0.25)
gnancy weight and SBP at 8 weeks (except for models with prepregnancy weight as the exposure) and GWG and SBP change prior to
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SUPPLEMENTARY TABLE 5
Associations of prepregnancy weight and GWG with subsequent DBP chan a
Weight variable
DBP at
8 wks, mm Hg
Average DBP change, mm
Early pregnancy
(8-18 wks)
Mean
difference 95% CI
Mean
difference 95% CI
Prepregnancy weight (10 kg)
Model 1 1.58 (1.35e1.81) 0.01 (e0.02 to 0.04
Average weight change
(200 g/wk)
Early pregnancy (0-18 wks) Model 1 0.01 (e0.03 to 0.04
Model 2 0.03 (0.00e0.05)
Midpregnancy (18-29 wks) Model 1
Model 2
Late pregnancy (29 wks) Model 1
Model 2
CI, confidence interval; DBP, diastolic blood pressure; GWG, gestational weight gain.
a Model 1 was adjusted for maternal height, age, parity, smoking, education, and offspring sex. Model 2 was also adjusted for prepre
the exposure period.
Macdonald-Wallis. Weight gain and blood pressure in pregnancy. Am J Obstet Gynecol 2013.
R
esea
327.e14
A
m
erican
Journalof
O
bstetrics
&
G
ynecology
O
C
TO
B
ER
2013ge (n[ 7975)
Hg/wkMidpregnancy
(18-29 wks)
Late pregnancy
(29-36 wks)
Very late pregnancy
(‡36 wks)
Mean
difference 95% CI
Mean
difference 95% CI
Mean
difference 95% CI
) e0.05 (e0.07 to e0.03) 0.02 (e0.01 to 0.05) e0.04 (e0.09 to 0.02)
) 0.04 (0.02e0.06) e0.04 (e0.08 to e0.01) 0.01 (e0.06 to 0.08)
0.03 (0.00e0.05) e0.05 (e0.08 to e0.01) 0.01 (e0.07 to 0.08)
0.05 (0.02e0.07) 0.00 (e0.04 to 0.03) 0.03 (e0.04 to 0.10)
0.04 (0.01e0.06) 0.01 (e0.03 to 0.06) 0.01 (e0.07 to 0.10)
0.05 (0.02e0.08) 0.08 (0.02e0.15)
0.08 (0.04e0.12) 0.10 (0.01e0.18)
gnancy weight and DBP at 8 weeks (except for models with prepregnancy weight as the exposure) and GWG and DBP change prior to
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SUPPLEMENTARY TABLE 6
Associations of baseline blood pressure and changes in blood pressure with subsequent GWG (n[ 7975)a
Blood pressure variable
Mean difference in average weight change, 200 g/wk
Early pregnancy (0-18 wks) Mid-pregnancy (18-29 wks) Late pregnancy (‡29 wks)
SBP at 8 wks (baseline), 5 mm Hg
Model 1 e0.05 (e0.08 to e0.01) e0.04 (e0.07 to e0.02) e0.02 (e0.05 to 0.02)
Model 2 0.04 (e0.00 to 0.07) e0.02 (e0.05 to 0.01) e0.01 (e0.05 to 0.02)
SBP change, mm Hg/wk
Early pregnancy (8-18 wks) Model 1 0.08 (e0.03 to 0.20) 0.05 (e0.08 to 0.18)
Model 2 0.06 (e0.06 to 0.18) 0.03 (e0.09 to 0.16)
Midpregnancy (18-29 wks) Model 1 0.21 (0.07e0.37)
Model 2 e0.01 (e0.17 to 0.15)
DBP at 8 wks (baseline) (5 mmHg)
Model 1 e0.07 (e0.13 to e0.02) e0.06 (e0.11 to e0.02) e0.05 (e0.10 to e0.00)
Model 2 0.06 (0.00e0.12) e0.03 (e0.08 to 0.02) e0.04 (e0.10 to 0.01)
DBP change, mm Hg/wk
Early pregnancy (8-18 wks) Model 1 0.08 (e0.11 to 0.27) 0.12 (e0.09 to 0.34)
Model 2 0.02 (e0.18 to 0.24) 0.06 (e0.15 to 0.30)
Midpregnancy (18-29 wks) Model 1 0.29 (0.08e0.50)
Model 2 0.14 (e0.06 to 0.36)
CI, confidence interval; DBP, diastolic blood pressure; GWG, gestational weight gain; SBP, systolic blood pressure.
a Model 1 was adjusted for maternal height, age, parity, smoking during pregnancy, education, and offspring sex. Model 2 was also adjusted for prepregnancy weight and SBP/DBP at 8 weeks, GWG
and SBP/DBP in all periods of pregnancy prior to the exposure period, and GWG in the exposure period.
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SUPPLEMENTARY FIGURE 1
Distribution of prepregnancy BMI (n[ 10,411)
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Distribution of GWG up to 18 weeks (n[ 11,760)
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